Skip to main content
. 2013 Sep 9;8(9):e73732. doi: 10.1371/journal.pone.0073732

Figure 2. Ac-PAL-AMC is hydrolyzed selectively by β1i.

Figure 2

(a) Chemical structure of Ac-PAL-AMC. (b) Ac-PAL-AMC hydrolysis over time by purified constitutive proteasome (cross), purified immunoproteasome (closed circle), or purified immunoproteasome pre-treated with UK101 (open square). A linear increase was seen in immunoproteasome-containing wells only. (c) The rate of hydrolysis of Ac-PAL-AMC or Suc-LLVY-AMC in the presence of Panc-1 cell extract (10 µg). Hydrolysis of Ac-PAL-AMC was almost completely inhibited by UK101 pre-treatment (10 µM). Hydrolysis of Suc-LLVY-AMC was partially inhibited by UK-101 pre-treatment. Epoxomicin (Epx, 10 µM), a broadly-acting proteasome inhibitor, was used as a positive control.